$62.09+$0.58 (+0.94%)as of market close, Jul 24, 2026
BMY — Bristol-Myers Squibb Company stock price, chart and key statistics
Key stats
Price data
- Price
- $62.09
- Change YTD
- +16.14%
- Next earnings
- Jul 30, 2026 · Before open
- Market cap
- 126.8B
- Enterprise value
- 159.4B
- Shares outstanding
- 2B
- 52W low
- $42.52
- 52W high
- $62.89
- From 52W high
- -1.27%
- From 52W low
- +46.03%
- 52W range
- 96%
- Beta
- 0.23
Volume
- Rel volume
- 1.18×
- 30D volume
- 12M
- 30D $ vol
- 689.4M
Fundamentals
- Sales (ttm)
- 48.5B
- Sales/share
- $23.74
- EPS (ttm)
- $3.55
- FCF (ttm)
- 11.9B
- FCF/share
- $5.83
- Book value/share
- $9.83
- Net margin
- 15.01%
- ROE
- 36.25%
- ROA
- 8.41%
- Debt / equity
- 2.10×
- Current ratio
- 1.42
Growth (CAGR, ttm) · 10Y
- Sales
- +11.11%
- Net income
- +16.54%
- FCF
- +43.36%
- Shares
- +2.04%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +14.35%
- Sales/share
- +8.89%
- FCF/share
- +40.50%
- Book value/share
- +1.32%
- Dividend/share
- +5.24%
- Price
- -1.96%
- Total return
- +2.68%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 17.4×
- Fwd P/E
- 9.9×
- P/S (ttm)
- 2.6×
- P/B (mrq)
- 6.3×
- P/FCF (ttm)
- 10.6×
- EV/Sales (ttm)
- 3.3×
- FCF yield (ttm)
- 9.39%
- Dividend yield (fwd)
- 4.06%
- Dividend/share (fwd)
- $2.52
- Buyback yield (ttm)
- 0.00%
- Shareholder yield (ttm)
- 4.00%
Vs own 10Y history
- P/E
- 32nd
- P/S
- 28th
- P/B
- 79th
- P/FCF
- 40th
Bar = where today's multiple sits in BMY's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
+0.94%
1W
+2.22%
1M
+12.89%
3M
+5.20%
YTD
+16.14%
1Y
+26.77%
5Y
-7.74%
Financial statements
Open full BMY financials →Related Healthcare
1MBristol-Myers Squibb Company (BMY) trades at $62.09 with a live price and an interactive chart covering 54+ years of daily price history, plus key valuation metrics. ChartRow also publishes BMY's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BMY financial statements →
